CurrentRheuma
Get Weekly

Topic · page 2 of 17

Systemic sclerosis & Raynaud's

Limited and diffuse systemic sclerosis, skin, lung (interstitial lung disease), pulmonary arterial hypertension, heart, gut and kidney involvement in systemic sclerosis, digital ulcers, primary and secondary Raynaud's phenomenon, very early systemic sclerosis

Briefs 41–80 of 671 placed here, newest publication first

Briefs in Systemic sclerosis & Raynaud's

Newest publication first

  1. Arthritis Care Res (Hoboken)

    Adopting a Standard of Care for Systemic Sclerosis: The Mayo Clinic Experience

    Cohort study

  2. Ann Rheum Dis

    Circulating biomarkers in patients with systemic sclerosis–associated interstitial lung disease in the SENSCIS trial

    Secondary analysis

  3. Rheumatology (Oxford)

    High levels of vascular cell adhesion molecule-1 associate with a ‘vasculopathic’ phenotype in systemic sclerosis with higher mortality

    Cohort study

  4. Ann Rheum Dis

    High-throughput plasma proteomics reveals circulating biomarkers of interstitial lung disease and progressive pulmonary fibrosis in systemic sclerosis

    Diagnostic or prognostic study

  5. Arthritis Care Res (Hoboken)

    Association of Elevated Platelets and C‐Reactive Protein With Severe Disease and Poor Survival in Systemic Sclerosis

    Cohort study

  6. RMD Open

    Expert viewpoint on endpoints in systemic sclerosis: current and future outlook

    Research article

  7. RMD Open

    Assessment of markers of primary aldosteronism in systemic sclerosis and their relationships with renal and cardiovascular outcomes

    Cohort study

  8. Arthritis Res Ther

    Real-world treatment patterns and determinants of therapy in systemic sclerosis: findings from the German Network for SSc cohort

    Cohort study

  9. Ann Rheum Dis

    Phenotype-specific associations of mosaic chromosomal alterations in systemic sclerosis

    Case-control study

  10. Rheumatology (Oxford)

    Automated high-resolution CT analysis outperforms visual assessment in predicting interstitial lung disease progression in SSc

    Cohort study

  11. Rheumatology (Oxford)

    The prevalence and incidence of Raynaud’s in England, United Kingdom

    Cohort study

  12. Arthritis Care Res (Hoboken)

    Understanding the Burden of Orofacial Involvement and Patient Treatment Preferences in Systemic Sclerosis: Results From a Large International Survey

    Cross-sectional study

  13. Rheumatology (Oxford)

    Clinical and autoantibody associations with malignancy in systemic sclerosis: a systematic review and meta-analysis

    Meta-analysis

  14. Rheumatology (Oxford)

    Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell activating factor levels and a B cell subset-wide reduction of BAFF-receptor expression in SSc

    Cross-sectional study

  15. Semin Arthritis Rheum

    Evaluating unsupervised and rule-based phenotyping methods versus administrative code counts for systemic sclerosis identification

    Diagnostic or prognostic study

  16. Arthritis Care Res (Hoboken)

    Engagement Patterns With an Artificial Intelligence Health Coach for Systemic Sclerosis Self‐Management: A Mixed Methods Study

    Research article

  17. Semin Arthritis Rheum

    Imaging techniques for assessing the hand in systemic sclerosis: a systematic review

    Meta-analysis

  18. Semin Arthritis Rheum

    Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosis

    Cohort study

  19. Arthritis Care Res (Hoboken)

    Anorectal Dysfunction in Systemic Sclerosis: Clinical Phenotypes and Functional Patterns

    Cohort study

  20. Arthritis Rheumatol

    Fibroblast Mitochondrial Ca 2+ Overload Drives Skin Fibrosis via Mitochondrial DNA Leakage and Cyclic GMP ‐ AMP Synthase–Stimulator of Interferon Genes Activation in Systemic Sclerosis

    Mechanistic study

  21. Arthritis Care Res (Hoboken)

    Determinants of Body Mass Index in Early Systemic Sclerosis: Implications for Nutritional Risk Stratification

    Cohort study

  22. Semin Arthritis Rheum

    Fibrosing myopathy in systemic sclerosis: Treatment response and clinical outcomes in a distinct subset

    Cohort study

  23. Ann Rheum Dis

    Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series

    Cohort study

  24. Ann Rheum Dis

    Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis—a case series

    Cohort study

  25. Arthritis Care Res (Hoboken)

    Real‐World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the EUSTAR Cohort

    Cohort study

  26. Rheumatology (Oxford)

    Scleroderma calcinosis cutis score (SC2S): an imaging metric to quantify SSc-calcinosis cutis

    Research article

  27. RMD Open

    Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian study

    Cohort study

  28. Rheumatology (Oxford)

    Prospective evaluation of recombinant Herpes zoster vaccine in SSc: immunogenicity, safety and disease outcomes

    Secondary analysis

  29. Semin Arthritis Rheum

    Incidence of malignancy in systemic sclerosis: A systematic review and meta-analysis

    Meta-analysis

  30. Ann Rheum Dis

    Pulmonary arterial hypertension susceptibility and mortality among patients with systemic sclerosis with the DNASE1L3 rs35677470 (Arg206Cys) variant

    Meta-analysis

  31. Semin Arthritis Rheum

    Identifying candidate core domains for clinical trials in systemic sclerosis-associated Raynaud’s phenomenon and digital ulcers

    Guideline or statement

  32. Semin Arthritis Rheum

    Multimodal imaging evaluation of pre-systemic sclerosis patients presenting with Raynaud’s Phenomenon from a reference microcirculatory clinic versus healthy controls: a cross-sectional study

    Cross-sectional study

  33. Arthritis Care Res (Hoboken)

    Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?

    Cohort study

  34. Arthritis Care Res (Hoboken)

    The Gut–Heart Axis in Systemic Sclerosis: Evidence From a Large Prospective Early Disease Cohort

    Cohort study

  35. Arthritis Rheumatol

    Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

    Cohort study

  36. Ann Rheum Dis

    Novel HLA class I and II insights into the pathogenesis of systemic sclerosis–associated interstitial lung disease

    Meta-analysis

  37. Rheumatology (Oxford)

    The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis

    Cross-sectional study

  38. Rheumatology (Oxford)

    Early gastrointestinal manifestations predict disease progression and mortality in patients with systemic sclerosis

    Cohort study

  39. RMD Open

    Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology

    Cohort study

  40. Arthritis Rheumatol

    Cytokine Profiling of Systemic Sclerosis–Related Pulmonary Hypertension

    Diagnostic or prognostic study

All 671 Briefs in ExploreShowing Briefs 41–80 of 671, newest first